These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7861629)

  • 1. [Evaluation of the special therapies in fulminant viral hepatitis--a multi-institution study].
    Takahashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 Jan; 92(1):7-18. PubMed ID: 7861629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.
    O'Grady JG; Gimson AE; O'Brien CJ; Pucknell A; Hughes RD; Williams R
    Gastroenterology; 1988 May; 94(5 Pt 1):1186-92. PubMed ID: 3280388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of combined plasma exchange treatment in fulminant viral hepatitis].
    Markus R; Baumgarten R; Fengler JD; Bartke D; Binus R; Fischer J; Kilger B; Miersch H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):197-204. PubMed ID: 4085389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome.
    Acharya SK; Dasarathy S; Kumer TL; Sushma S; Prasanna KS; Tandon A; Sreenivas V; Nijhawan S; Panda SK; Nanda SK; Irshad M; Joshi YK; Duttagupta S; Tandon RK; Tandon BN
    Hepatology; 1996 Jun; 23(6):1448-55. PubMed ID: 8675163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved prognosis of fulminant hepatitis by a simple supportive therapeutic regimen.
    Tandon BN; Sharma MP; Tandon RK; Koshy A; Narendranathan M; Mazumdar TN
    Indian J Med Res; 1978 Mar; 67():401-5. PubMed ID: 689714
    [No Abstract]   [Full Text] [Related]  

  • 6. [Imbalance of amino acid metabolism in fulminant hepatitis and its management].
    Kato A; Suzuki K; Sato S
    Nihon Rinsho; 1992 Jul; 50(7):1599-603. PubMed ID: 1404890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemoperfusion adsorption and supporting from artificial liver].
    Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):503. PubMed ID: 12939191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
    Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
    Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodialysis with a high permeability membrane in the treatment of encephalopathy of fulminant hepatitis].
    Gardère JJ; Castaing Y; Gbikpi-Bénissan G
    Ann Fr Anesth Reanim; 1987; 6(5):423-8. PubMed ID: 3434887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hemoperfusion adsorption and/or plasma exchange in treatment of severe viral hepatitis: a comparative study.
    He NH; Wang YJ; Wang ZW; Liu J; Li JJ; Liu GD; Wang YM
    World J Gastroenterol; 2004 Apr; 10(8):1218-21. PubMed ID: 15069730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
    Schmidt LE; Tofteng F; Strauss GI; Larsen FS
    Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis-hemoperfusion in fulminant viral hepatitis.
    Ramos CP; Almario JS
    Biomater Artif Cells Artif Organs; 1990; 18(5):689-92. PubMed ID: 2099225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of fulminant hepatitis with hemoperfusion].
    Gomis Gavilán M; Pastor Gómez J; Fernández López J; Fuentes Domínguez A; Fanlo Abella B; Junquera Prats E; Narvéz García R; Quiroga Merino L
    Rev Clin Esp; 1985 Feb; 176(2):105-6. PubMed ID: 3991945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of prognostic factors of and to establish a predictive model for patients with chronic severe hepatitis].
    Zhang N; Wang YM; Deng GH; Yi D
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):730-3. PubMed ID: 16248942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1984 Jul; 7(4):203-8. PubMed ID: 6490192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances in the treatment of decompensated liver cirrhosis].
    Moriwaki H; Kato M; Murase M; Muto Y
    Nihon Rinsho; 1994 Jan; 52(1):192-6. PubMed ID: 8114292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of normalization of plasma amino acids on hepatic encephalopathy in man.
    Fischer JE; Rosen HM; Ebeid AM; James JH; Keane JM; Soeters PB
    Surgery; 1976 Jul; 80(1):77-91. PubMed ID: 818729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.